FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis
Abstract FKBP4, a member of the FK506-binding protein (FKBP) family, is a promising target for a variety of disorders, including cancer. However, its underlying molecular mechanism and potential function in hepatocellular carcinoma (HCC) are largely elusive. Therefore, we aimed to investigate the ex...
Saved in:
| Main Authors: | Zhenzhen Zeng, Shasha Xu, Ruihua Wang, Xingmin Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-78383-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Daurisoline inhibits glycolysis of lung cancer by targeting the AKT-HK2 axis
by: Shi-Ming Tan, et al.
Published: (2025-12-01) -
LAMB1 downregulation suppresses glioma progression by inhibiting aerobic glycolysis through regulation of the NF-κB/HK2 axis
by: Zhenxiang Zhao, et al.
Published: (2025-02-01) -
Regulatory factor X‐5/SCL/TAL1 interruption site axis promotes aerobic glycolysis and hepatocellular carcinoma cell stemness
by: Zhi‐Zhong Zhang, et al.
Published: (2025-01-01) -
The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis
by: Qin Qi, et al.
Published: (2025-02-01) -
Mitochondrial dysfunction-driven AMPK-p53 axis activation underpins the anti-hepatocellular carcinoma effects of sulfane sulfur
by: Xue Zheng, et al.
Published: (2025-01-01)